Site search

Historical publications

Historical publications tell the story of the Royal Melbourne Hospital, our services and our people.

Bitopertin as a treatment for erythropoietic protoporphyria Research study

Research project to measure how safe and effective bitopertin (DISC-1459) is in treating participants with erythropoietic protoporphyria.

The PRolaCT-O study Research study

Since 2023, the international recommendation is either medication or surgery as first-line therapy for small and well-localised prolactinomas. However, there is a lack of prospective studies comparing outcomes and evaluating quality of life. 

Prepare for and attend your surgery

When it is time for your planned surgery, we will notify you of your procedure date. You may also need to attend a Pre-Admission Clinic appointment.

New study paves the way for more effective COVID-19 research and treatment News article

A Melbourne-led study, involving researchers from the Royal Melbourne Hospital (RMH), suggests that a primary tissue culture model is more effective at recreating the human experience of COVID-19, leading to more accurate treatments for the condition.

New MS study tackles invisible side of condition News article

Today is World MS Day. Multiple Sclerosis (MS) is a chronic disabling neurological condition which affects over 33,000 Australians. As the home of the largest Neuroimmunology Centre in Australia, our clinicians see how devastating the condition can be for patients and their loved ones, as people...

New tech partnership to help staff and patients News article

The RMH is partnering with ANDHealth to deliver new tech solutions for staff and patients.

NeuronCare: An Acute Neurological Physiotherapy course

NeuronCare is a professional development and training program for early career physiotherapists that combines virtual and face-to-face training. The course runs over 5 weeks from 3 June 2026.

COVID-19 guidance for clinical trials and research projects

The safety and wellbeing of trial participants, other patients, visitors, researchers and other clinical and support staff is paramount.

Experimental treatment for Parkinson’s disease Research study

This is a study of an experimental treatment (referred to as “study drug”) called CVL-751 as a possible treatment for Parkinson’s disease.

Shining a light on a different kind of ‘Bluey’ this Operation Clean Up Day News article

A team of passionate sustainability champions have changed the way the RMH thinks of Bluey – not only an adorable dog, but a crucial piece of equipment contributing to unnecessary waste.

Clinical trial assessing the safety and effectiveness of a potential new treatment for plaque psoriasis Research study

This study aims to assess efficacy and safety of JNJ-77242113 compared to placebo and ustekinumab in people with moderate to severe Plaque Psoriasis.

Launching our second Reconciliation Action Plan News article

The Royal Melbourne Hospital celebrates the launch of our Innovate RAP.

Trial to assess a new tablet for plaque psoriasis Research study

Plaque psoriasis is an autoimmune condition characterised by dry, itchy and scaly skin patches. This trial investigates whether people with plaque psoriasis may be able to take an oral treatment to improve the condition.

Second life-saving stroke service hits the road News article

A second, life-saving Mobile Stroke Unit has hit the road - doubling the service’s reach across Melbourne.

Honours for former RMH staff News article

Six Victorians with ties to the RMH have been named in the Australia Day 2026 Honours.

Mental health social work

Social workers are the largest allied health workforce in public mental health, employed in a range of roles at all levels of the organisation.

Section 4: For projects that involve radiation or genetically modified organisms

Requirements for RMH research using ionising radiation or GMOs, including physicist review, OGTR obligations, licensing, IBC review and participant information.

Brain interface proves to be safe and effective News article

A device the size of a small paperclip, created to give people with severe paralysis the ability to communicate again, has been shown to be safe.

When music festivals return new research reveals insight to overdoses News article

The world’s largest study of recreational drug-induced serotonin toxicity has highlighted the potentially dire consequences of drug use at music festivals in Victoria.